BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med 2005;7:463-78. [PMID: 16170238 DOI: 10.1097/01.gim.0000177530.55043.c1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Marshall AL, Christiani DC. Genetic susceptibility to lung cancer--light at the end of the tunnel? Carcinogenesis 2013;34:487-502. [PMID: 23349013 DOI: 10.1093/carcin/bgt016] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
2 Hyun DH. Plasma membrane redox enzymes: new therapeutic targets for neurodegenerative diseases. Arch Pharm Res 2019;42:436-45. [PMID: 30919268 DOI: 10.1007/s12272-019-01147-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Park JH, Park JM, Kim EJ, Cha SI, Lee EB, Kim CH, Kam S, Jung TH, Yong Park J. Myeloperoxidase −463G>A polymorphism and risk of primary lung cancer in a Korean population. Cancer Detection and Prevention 2006;30:257-61. [DOI: 10.1016/j.cdp.2006.04.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
4 Liu F, Luo L, Wei Y, Wang W, Li B, Yan L, Wen T. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population. Tumor Biol 2013;34:47-53. [DOI: 10.1007/s13277-012-0509-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
5 Wang Y, Yang H, Li L, Wang H, Zhang C, Yin G, Zhu B. Association between CYP2E1 genetic polymorphisms and lung cancer risk: A meta-analysis. European Journal of Cancer 2010;46:758-64. [DOI: 10.1016/j.ejca.2009.12.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
6 Hemissi I, Ayed H, Naimi Z, Meddeb K, Ayadi M, Zouari S, Zaghbib S, Talbi E, Chebil M, Ouerhani S. Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population. Mol Genet Genomic Med 2021;9:e1819. [PMID: 34549902 DOI: 10.1002/mgg3.1819] [Reference Citation Analysis]
7 Gaikwad NW, Yang L, Rogan EG, Cavalieri EL. Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones. Free Radic Biol Med. 2009;46:253-262. [PMID: 18996184 DOI: 10.1016/j.freeradbiomed.2008.10.029] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
8 Ye X, Song L, Peng L, Bu Z, Yan S, Feng J, Zhu X, Liao X, Yu X, Yan D. Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis. Mol Genet Genomics 2015;290:545-58. [DOI: 10.1007/s00438-014-0941-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
9 Troy JD, Weissfeld JL, Diergaarde B, Youk AO, Buch SC, Romkes M, Grandis JR. Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer. Cancer Epidemiol 2013;37:505-11. [PMID: 23523331 DOI: 10.1016/j.canep.2013.02.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Prawan A, Buranrat B, Kukongviriyapan U, Sripa B, Kukongviriyapan V. Inflammatory cytokines suppress NAD(P)H:quinone oxidoreductase-1 and induce oxidative stress in cholangiocarcinoma cells. J Cancer Res Clin Oncol 2009;135:515-22. [DOI: 10.1007/s00432-008-0483-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
11 Landi MT, Consonni D, Rotunno M, Bergen AW, Goldstein AM, Lubin JH, Goldin L, Alavanja M, Morgan G, Subar AF, Linnoila I, Previdi F, Corno M, Rubagotti M, Marinelli B, Albetti B, Colombi A, Tucker M, Wacholder S, Pesatori AC, Caporaso NE, Bertazzi PA. Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health 2008;8:203. [PMID: 18538025 DOI: 10.1186/1471-2458-8-203] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 6.4] [Reference Citation Analysis]
12 Fu Y, Buryanovskyy L, Zhang Z. Quinone reductase 2 is a catechol quinone reductase. J Biol Chem 2008;283:23829-35. [PMID: 18579530 DOI: 10.1074/jbc.M801371200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
13 Minelli C, Wei I, Sagoo G, Jarvis D, Shaheen S, Burney P. Interactive effects of antioxidant genes and air pollution on respiratory function and airway disease: a HuGE review. Am J Epidemiol. 2011;173:603-620. [PMID: 21343247 DOI: 10.1093/aje/kwq403] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 6.5] [Reference Citation Analysis]
14 Kucera HR, Livingstone M, Moscoso CG, Gaikwad NW. Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides. Free Radic Res 2013;47:1016-26. [PMID: 24074361 DOI: 10.3109/10715762.2013.847527] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
15 Gaikwad NW, Rogan EG, Cavalieri EL. Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med. 2007;43:1289-1298. [PMID: 17893042 DOI: 10.1016/j.freeradbiomed.2007.07.02] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Gaikwad NW, Rogan EG, Cavalieri EL. Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med 2007;43:1289-98. [PMID: 17893042 DOI: 10.1016/j.freeradbiomed.2007.07.021] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
17 Buch SC, Nazar-Stewart V, Weissfeld JL, Romkes M. Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes. Head Neck 2008;30:1139-47. [PMID: 18642288 DOI: 10.1002/hed.20867] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
18 Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 2008;167:759-74. [PMID: 18270371 DOI: 10.1093/aje/kwm383] [Cited by in Crossref: 117] [Cited by in F6Publishing: 100] [Article Influence: 8.4] [Reference Citation Analysis]
19 Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsière T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res. 2008;658:215-233. [PMID: 18037339 DOI: 10.1016/j.mrrev.2007.10.001] [Cited by in Crossref: 125] [Cited by in F6Publishing: 114] [Article Influence: 8.3] [Reference Citation Analysis]
20 Moumad K, Khaali W, Benider A, Ben Ayoub W, Hamdi-Cherif M, Boualga K, Hassen E, Ben Driss EK, Corbex M, Khyatti M. Joint effect of smoking and NQO1 C609T polymorphism on undifferentiated nasopharyngeal carcinoma risk in a North African population. Mol Genet Genomic Med 2018;6:933-40. [PMID: 30160047 DOI: 10.1002/mgg3.461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
21 Li J, Fu Y, Zhao B, Xiao Y, Chen R. Myeloperoxidase G463A polymorphism and risk of lung cancer. Tumor Biol 2014;35:821-9. [DOI: 10.1007/s13277-013-1113-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
22 Bull LM, White DL, Bray M, Nurgalieva Z, El-Serag HB. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus 2009;22:571-87. [PMID: 19222528 DOI: 10.1111/j.1442-2050.2009.00947.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
23 Matakova T, Sivonova M, Halasova E, Mistuna D, Dzian A, Berzinec P, Letkova L, Dobrota D. Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population. Eur J Med Res 2009;14 Suppl 4:275-9. [PMID: 20156772 DOI: 10.1186/2047-783x-14-s4-275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
24 Taioli E, Benhamou S, Bouchardy C, Cascorbi I, Cajas-Salazar N, Dally H, Fong KM, Larsen JE, Le Marchand L, London SJ, Risch A, Spitz MR, Stucker I, Weinshenker B, Wu X, Yang P. Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genet Med 2007;9:67-73. [PMID: 17304047 DOI: 10.1097/gim.0b013e31803068b1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
25 Lou Y, Li R, Xiong L, Gu A, Shi C, Chu T, Zhang X, Gu P, Zhong H, Wen S, Han B. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis. Tumor Biol 2013;34:3967-79. [DOI: 10.1007/s13277-013-0985-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
26 Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. Lung cancer susceptibility: are we on our way to identifying a high-risk group? Future Oncology 2007;3:617-27. [DOI: 10.2217/14796694.3.6.617] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
27 Hildebrandt MA, Gu J, Wu X. Pharmacogenomics of platinum-based chemotherapy in NSCLC. Expert Opin Drug Metab Toxicol 2009;5:745-55. [PMID: 19442035 DOI: 10.1517/17425250902973711] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
28 Li C, Chen W, Zhang M, Zhang C, Cao B, Dong B, Qi S, Zhang Y, Fei X, Li X, Li R, Wang J, Li G. Modulatory effects of Xihuang Pill on lung cancer treatment by an integrative approach. Biomed Pharmacother 2020;130:110533. [PMID: 32739739 DOI: 10.1016/j.biopha.2020.110533] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Cassidy A, Field JK. Environmental and Genetic Risk Factors of Lung Cancer. Outcome Prediction in Cancer. Elsevier; 2007. pp. 67-100. [DOI: 10.1016/b978-044452855-1/50006-4] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
30 Tysklind N, Taylor MI, Lyons BP, Goodsir F, McCarthy ID, Carvalho GR. Population genetics provides new insights into biomarker prevalence in dab (Limanda limanda L.): a key marine biomonitoring species. Evol Appl 2013;6:891-909. [PMID: 24062799 DOI: 10.1111/eva.12074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
31 Punia S, Das M, Behari M, Dihana M, Govindappa ST, Muthane UB, Thelma BK, Juyal RC. Leads from xenobiotic metabolism genes for Parkinson's disease among north Indians. Pharmacogenet Genomics 2011;21:790-7. [PMID: 22016051 DOI: 10.1097/FPC.0b013e32834bcd74] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
32 Nymark P, Wikman H, Hienonen-Kempas T, Anttila S. Molecular and genetic changes in asbestos-related lung cancer. Cancer Lett 2008;265:1-15. [PMID: 18364247 DOI: 10.1016/j.canlet.2008.02.043] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
33 He C, Tamimi RM, Hankinson SE, Hunter DJ, Han J. A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk. Breast Cancer Res Treat 2009;113:585-94. [PMID: 18340529 DOI: 10.1007/s10549-008-9962-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
34 Huang C, Ma L, Li D. Association between myeloperoxidase G-463A polymorphism and lung cancer risk. Tumour Biol 2014;35:475-81. [PMID: 23943392 DOI: 10.1007/s13277-013-1067-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006;54:267-83. [PMID: 16982113 DOI: 10.1016/j.lungcan.2006.08.009] [Cited by in Crossref: 129] [Cited by in F6Publishing: 107] [Article Influence: 8.1] [Reference Citation Analysis]
36 Lu F, Zahid M, Wang C, Saeed M, Cavalieri EL, Rogan EG. Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev Res (Phila) 2008;1:135-45. [PMID: 19138946 DOI: 10.1158/1940-6207.CAPR-08-0037] [Cited by in Crossref: 74] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
37 Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer. 2008;123:1-7. [PMID: 18425819 DOI: 10.1002/ijc.23605] [Cited by in Crossref: 153] [Cited by in F6Publishing: 138] [Article Influence: 10.9] [Reference Citation Analysis]
38 Geary B, Walker MJ, Snow JT, Lee DCH, Pernemalm M, Maleki-dizaji S, Azadbakht N, Apostolidou S, Barnes J, Krysiak P, Shah R, Booton R, Dive C, Crosbie PA, Whetton AD. Identification of a Biomarker Panel for Early Detection of Lung Cancer Patients. J Proteome Res 2019;18:3369-82. [DOI: 10.1021/acs.jproteome.9b00287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
39 Heller A. Apoptosis-inducing high (.)NO concentrations are not sustained either in nascent or in developed cancers. ChemMedChem 2008;3:1493-9. [PMID: 18759245 DOI: 10.1002/cmdc.200800257] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
40 Yang M, Choi Y, Hwangbo B, Lee JS. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 2007;57:135-42. [DOI: 10.1016/j.lungcan.2007.03.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
41 Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in the inflammatory response and lung cancer risk: A case-control study in Japan. Cytokine 2014;65:88-94. [DOI: 10.1016/j.cyto.2013.09.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
42 Opgen-rhein C, Dettling M. Clozapine-induced agranulocytosis and its genetic determinants. Pharmacogenomics 2008;9:1101-11. [DOI: 10.2217/14622416.9.8.1101] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
43 Mondal NK, Saha H, Mukherjee B, Tyagi N, Ray MR. Inflammation, oxidative stress, and higher expression levels of Nrf2 and NQO1 proteins in the airways of women chronically exposed to biomass fuel smoke. Mol Cell Biochem 2018;447:63-76. [DOI: 10.1007/s11010-018-3293-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
44 Zhang H, Wen X, Lu X, Zhang H. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer. Tumour Biol 2013;34:3377-81. [PMID: 23873104 DOI: 10.1007/s13277-013-0909-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
45 Boddupalli S, Mein JR, Lakkanna S, James DR. Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins a, C, and e. Front Genet 2012;3:7. [PMID: 22303412 DOI: 10.3389/fgene.2012.00007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
46 Wenten M, Gauderman WJ, Berhane K, Lin PC, Peters J, Gilliland FD. Functional variants in the catalase and myeloperoxidase genes, ambient air pollution, and respiratory-related school absences: an example of epistasis in gene-environment interactions. Am J Epidemiol 2009;170:1494-501. [PMID: 19897513 DOI: 10.1093/aje/kwp310] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
47 Sampath V, Garland JS, Helbling D, Dimmock D, Mulrooney NP, Simpson PM, Murray JC, Dagle JM. Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants. Pediatr Res 2015;77:477-83. [PMID: 25518008 DOI: 10.1038/pr.2014.200] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
48 Monisha J, Roy NK, Padmavathi G, Banik K, Bordoloi D, Khwairakpam AD, Arfuso F, Chinnathambi A, Alahmadi TA, Alharbi SA, Sethi G, Kumar AP, Kunnumakkara AB. NGAL is Downregulated in Oral Squamous Cell Carcinoma and Leads to Increased Survival, Proliferation, Migration and Chemoresistance. Cancers (Basel) 2018;10:E228. [PMID: 29996471 DOI: 10.3390/cancers10070228] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
49 Price TS, Grosser T, Plomin R, Jaffee SR. Fetal genotype for the xenobiotic metabolizing enzyme NQO1 influences intrauterine growth among infants whose mothers smoked during pregnancy. Child Dev 2010;81:101-14. [PMID: 20331656 DOI: 10.1111/j.1467-8624.2009.01383.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
50 Huang J, Lin H, Wu X, Jin W, Zhang Z. NQO1 C609T polymorphism and lung cancer susceptibility: Evidence from a comprehensive meta-analysis. Oncotarget 2017;8:102301-9. [PMID: 29254245 DOI: 10.18632/oncotarget.21084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
51 Xue J, Yang S, Seng S. Mechanisms of Cancer Induction by Tobacco-Specific NNK and NNN. Cancers (Basel) 2014;6:1138-56. [PMID: 24830349 DOI: 10.3390/cancers6021138] [Cited by in Crossref: 103] [Cited by in F6Publishing: 91] [Article Influence: 12.9] [Reference Citation Analysis]
52 Parihar SS, Chauhan UK. The NQO1 allelic frequency in hindu population of central India varies from that of other Asian populations. Indian J Hum Genet 2010;16:133-7. [PMID: 21206700 DOI: 10.4103/0971-6866.73403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Hou X, Bai X, Gou X, Zeng H, Xia C, Zhuang W, Chen X, Zhao Z, Huang M, Jin J. 3',4',5',5,7-pentamethoxyflavone sensitizes Cisplatin-resistant A549 cells to Cisplatin by inhibition of Nrf2 pathway. Mol Cells 2015;38:396-401. [PMID: 25843086 DOI: 10.14348/molcells.2015.2183] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
54 Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA. NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am J Epidemiol 2008;168:1221-32. [PMID: 18945694 DOI: 10.1093/aje/kwn246] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
55 Wang S, Li J, Wang Y. M2PP: a novel computational model for predicting drug-targeted pathogenic proteins. BMC Bioinformatics 2022;23:7. [PMID: 34983358 DOI: 10.1186/s12859-021-04522-9] [Reference Citation Analysis]
56 Kim YJ, Choi JY, Paek D, Chung HW. Association of the NQO1, MPO, and XRCC1 polymorphisms and chromosome damage among workers at a petroleum refinery. J Toxicol Environ Health A 2008;71:333-41. [PMID: 18214807 DOI: 10.1080/15287390701738558] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
57 Fischer AJ, Goss KL, Scheetz TE, Wohlford-Lenane CL, Snyder JM, McCray PB Jr. Differential gene expression in human conducting airway surface epithelia and submucosal glands. Am J Respir Cell Mol Biol 2009;40:189-99. [PMID: 18703793 DOI: 10.1165/rcmb.2008-0240OC] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
58 Kolesar JM, Dahlberg SE, Marsh S, McLeod HL, Johnson DH, Keller SM, Schiller JH. The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer. Oncol Rep 2011;25:1765-72. [PMID: 21479364 DOI: 10.3892/or.2011.1249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
59 Gresner P, Gromadzinska J, Wasowicz W. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 2007;57:1-25. [PMID: 17337085 DOI: 10.1016/j.lungcan.2007.02.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]